<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1605123009056 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SABATES_COLORECTAL_ADENOMA_DN'>SABATES_COLORECTAL_ADENOMA_DN</a></td><td><a href='SABATES_COLORECTAL_ADENOMA_DN.html'>Details ...</a></td><td>19</td><td>-0.71</td><td>-2.10</td><td>0.000</td><td>0.072</td><td>0.149</td><td>100</td><td>tags=84%, list=24%, signal=106%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_DN'>SANSOM_APC_TARGETS_DN</a></td><td><a href='SANSOM_APC_TARGETS_DN.html'>Details ...</a></td><td>16</td><td>-0.71</td><td>-2.08</td><td>0.000</td><td>0.046</td><td>0.185</td><td>55</td><td>tags=50%, list=13%, signal=55%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/YOSHIMURA_MAPK8_TARGETS_UP'>YOSHIMURA_MAPK8_TARGETS_UP</a></td><td><a href='YOSHIMURA_MAPK8_TARGETS_UP.html'>Details ...</a></td><td>51</td><td>-0.53</td><td>-2.02</td><td>0.001</td><td>0.071</td><td>0.376</td><td>65</td><td>tags=33%, list=16%, signal=35%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP'>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</a></td><td><a href='CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP.html'>Details ...</a></td><td>25</td><td>-0.59</td><td>-1.92</td><td>0.010</td><td>0.159</td><td>0.741</td><td>92</td><td>tags=60%, list=22%, signal=72%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP'>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</a></td><td><a href='CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP.html'>Details ...</a></td><td>18</td><td>-0.61</td><td>-1.85</td><td>0.012</td><td>0.236</td><td>0.912</td><td>92</td><td>tags=61%, list=22%, signal=75%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SMID_BREAST_CANCER_BASAL_DN'>SMID_BREAST_CANCER_BASAL_DN</a></td><td><a href='SMID_BREAST_CANCER_BASAL_DN.html'>Details ...</a></td><td>35</td><td>-0.53</td><td>-1.84</td><td>0.008</td><td>0.219</td><td>0.924</td><td>123</td><td>tags=71%, list=29%, signal=93%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_DN'>ACEVEDO_LIVER_CANCER_DN</a></td><td><a href='ACEVEDO_LIVER_CANCER_DN.html'>Details ...</a></td><td>24</td><td>-0.57</td><td>-1.81</td><td>0.026</td><td>0.254</td><td>0.976</td><td>64</td><td>tags=38%, list=15%, signal=42%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MASSARWEH_TAMOXIFEN_RESISTANCE_UP'>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</a></td><td><a href='MASSARWEH_TAMOXIFEN_RESISTANCE_UP.html'>Details ...</a></td><td>26</td><td>-0.54</td><td>-1.74</td><td>0.036</td><td>0.347</td><td>1.000</td><td>43</td><td>tags=27%, list=10%, signal=28%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_GPCR'>REACTOME_SIGNALING_BY_GPCR</a></td><td><a href='REACTOME_SIGNALING_BY_GPCR.html'>Details ...</a></td><td>19</td><td>-0.59</td><td>-1.74</td><td>0.023</td><td>0.312</td><td>1.000</td><td>67</td><td>tags=53%, list=16%, signal=60%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MIKKELSEN_MEF_HCP_WITH_H3K27ME3'>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_MEF_HCP_WITH_H3K27ME3.html'>Details ...</a></td><td>18</td><td>-0.57</td><td>-1.72</td><td>0.040</td><td>0.336</td><td>1.000</td><td>92</td><td>tags=56%, list=22%, signal=68%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN'>JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN</a></td><td><a href='JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN.html'>Details ...</a></td><td>26</td><td>-0.50</td><td>-1.65</td><td>0.054</td><td>0.460</td><td>1.000</td><td>22</td><td>tags=19%, list=5%, signal=19%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MARTENS_TRETINOIN_RESPONSE_UP'>MARTENS_TRETINOIN_RESPONSE_UP</a></td><td><a href='MARTENS_TRETINOIN_RESPONSE_UP.html'>Details ...</a></td><td>22</td><td>-0.51</td><td>-1.60</td><td>0.063</td><td>0.554</td><td>1.000</td><td>60</td><td>tags=36%, list=14%, signal=40%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN'>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN</a></td><td><a href='VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN.html'>Details ...</a></td><td>16</td><td>-0.55</td><td>-1.57</td><td>0.077</td><td>0.621</td><td>1.000</td><td>21</td><td>tags=19%, list=5%, signal=19%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FEVR_CTNNB1_TARGETS_UP'>FEVR_CTNNB1_TARGETS_UP</a></td><td><a href='FEVR_CTNNB1_TARGETS_UP.html'>Details ...</a></td><td>56</td><td>-0.40</td><td>-1.53</td><td>0.059</td><td>0.689</td><td>1.000</td><td>60</td><td>tags=29%, list=14%, signal=29%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/NABA_ECM_AFFILIATED'>NABA_ECM_AFFILIATED</a></td><td><a href='NABA_ECM_AFFILIATED.html'>Details ...</a></td><td>16</td><td>-0.52</td><td>-1.52</td><td>0.100</td><td>0.697</td><td>1.000</td><td>34</td><td>tags=31%, list=8%, signal=33%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WANG_LMO4_TARGETS_UP'>WANG_LMO4_TARGETS_UP</a></td><td><a href='WANG_LMO4_TARGETS_UP.html'>Details ...</a></td><td>20</td><td>-0.49</td><td>-1.50</td><td>0.116</td><td>0.717</td><td>1.000</td><td>8</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP'>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</a></td><td><a href='SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP.html'>Details ...</a></td><td>32</td><td>-0.43</td><td>-1.47</td><td>0.113</td><td>0.771</td><td>1.000</td><td>49</td><td>tags=25%, list=12%, signal=26%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PROVENZANI_METASTASIS_UP'>PROVENZANI_METASTASIS_UP</a></td><td><a href='PROVENZANI_METASTASIS_UP.html'>Details ...</a></td><td>17</td><td>-0.50</td><td>-1.47</td><td>0.101</td><td>0.733</td><td>1.000</td><td>32</td><td>tags=18%, list=8%, signal=18%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_BASAL_VS_LULMINAL'>FARMER_BREAST_CANCER_BASAL_VS_LULMINAL</a></td><td><a href='FARMER_BREAST_CANCER_BASAL_VS_LULMINAL.html'>Details ...</a></td><td>19</td><td>-0.49</td><td>-1.46</td><td>0.130</td><td>0.725</td><td>1.000</td><td>8</td><td>tags=11%, list=2%, signal=10%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN'>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN</a></td><td><a href='JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN.html'>Details ...</a></td><td>25</td><td>-0.45</td><td>-1.43</td><td>0.121</td><td>0.769</td><td>1.000</td><td>24</td><td>tags=16%, list=6%, signal=16%</td></tr><tr><td class='lessen'>21</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td><td></td><td>21</td><td>-0.46</td><td>-1.43</td><td>0.122</td><td>0.739</td><td>1.000</td><td>100</td><td>tags=57%, list=24%, signal=71%</td></tr><tr><td class='lessen'>22</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN</td><td></td><td>19</td><td>-0.45</td><td>-1.35</td><td>0.187</td><td>0.962</td><td>1.000</td><td>79</td><td>tags=42%, list=19%, signal=50%</td></tr><tr><td class='lessen'>23</td><td>LEI_MYB_TARGETS</td><td></td><td>36</td><td>-0.38</td><td>-1.33</td><td>0.183</td><td>0.994</td><td>1.000</td><td>33</td><td>tags=17%, list=8%, signal=17%</td></tr><tr><td class='lessen'>24</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</td><td></td><td>18</td><td>-0.44</td><td>-1.29</td><td>0.258</td><td>1.000</td><td>1.000</td><td>12</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>25</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>15</td><td>-0.46</td><td>-1.28</td><td>0.251</td><td>1.000</td><td>1.000</td><td>115</td><td>tags=60%, list=28%, signal=80%</td></tr><tr><td class='lessen'>26</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</td><td></td><td>17</td><td>-0.44</td><td>-1.27</td><td>0.234</td><td>1.000</td><td>1.000</td><td>41</td><td>tags=24%, list=10%, signal=25%</td></tr><tr><td class='lessen'>27</td><td>NABA_MATRISOME_ASSOCIATED</td><td></td><td>32</td><td>-0.37</td><td>-1.27</td><td>0.226</td><td>1.000</td><td>1.000</td><td>76</td><td>tags=34%, list=18%, signal=39%</td></tr><tr><td class='lessen'>28</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN</td><td></td><td>17</td><td>-0.41</td><td>-1.22</td><td>0.307</td><td>1.000</td><td>1.000</td><td>100</td><td>tags=47%, list=24%, signal=59%</td></tr><tr><td class='lessen'>29</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</td><td></td><td>35</td><td>-0.35</td><td>-1.21</td><td>0.273</td><td>1.000</td><td>1.000</td><td>14</td><td>tags=9%, list=3%, signal=8%</td></tr><tr><td class='lessen'>30</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2</td><td></td><td>17</td><td>-0.42</td><td>-1.21</td><td>0.307</td><td>1.000</td><td>1.000</td><td>2</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>31</td><td>REACTOME_TRANSPORT_OF_SMALL_MOLECULES</td><td></td><td>22</td><td>-0.39</td><td>-1.21</td><td>0.290</td><td>1.000</td><td>1.000</td><td>118</td><td>tags=55%, list=28%, signal=72%</td></tr><tr><td class='lessen'>32</td><td>NABA_MATRISOME</td><td></td><td>34</td><td>-0.35</td><td>-1.21</td><td>0.275</td><td>1.000</td><td>1.000</td><td>34</td><td>tags=18%, list=8%, signal=18%</td></tr><tr><td class='lessen'>33</td><td>LIU_PROSTATE_CANCER_DN</td><td></td><td>18</td><td>-0.40</td><td>-1.21</td><td>0.284</td><td>1.000</td><td>1.000</td><td>11</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>34</td><td>WEST_ADRENOCORTICAL_TUMOR_DN</td><td></td><td>19</td><td>-0.39</td><td>-1.20</td><td>0.295</td><td>1.000</td><td>1.000</td><td>64</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>35</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>30</td><td>-0.35</td><td>-1.19</td><td>0.295</td><td>1.000</td><td>1.000</td><td>58</td><td>tags=23%, list=14%, signal=25%</td></tr><tr><td class='lessen'>36</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL</td><td></td><td>17</td><td>-0.41</td><td>-1.17</td><td>0.334</td><td>1.000</td><td>1.000</td><td>67</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>37</td><td>ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY</td><td></td><td>18</td><td>-0.39</td><td>-1.17</td><td>0.308</td><td>1.000</td><td>1.000</td><td>85</td><td>tags=39%, list=20%, signal=47%</td></tr><tr><td class='lessen'>38</td><td>BASAKI_YBX1_TARGETS_DN</td><td></td><td>25</td><td>-0.37</td><td>-1.16</td><td>0.326</td><td>1.000</td><td>1.000</td><td>69</td><td>tags=36%, list=17%, signal=41%</td></tr><tr><td class='lessen'>39</td><td>WINTER_HYPOXIA_METAGENE</td><td></td><td>22</td><td>-0.37</td><td>-1.16</td><td>0.327</td><td>0.991</td><td>1.000</td><td>18</td><td>tags=9%, list=4%, signal=9%</td></tr><tr><td class='lessen'>40</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7</td><td></td><td>21</td><td>-0.36</td><td>-1.13</td><td>0.352</td><td>1.000</td><td>1.000</td><td>4</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>41</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>16</td><td>-0.39</td><td>-1.13</td><td>0.375</td><td>1.000</td><td>1.000</td><td>6</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>42</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN</td><td></td><td>17</td><td>-0.38</td><td>-1.12</td><td>0.383</td><td>1.000</td><td>1.000</td><td>4</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>43</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>31</td><td>-0.33</td><td>-1.12</td><td>0.331</td><td>0.995</td><td>1.000</td><td>20</td><td>tags=10%, list=5%, signal=9%</td></tr><tr><td class='lessen'>44</td><td>HAN_SATB1_TARGETS_DN</td><td></td><td>18</td><td>-0.37</td><td>-1.10</td><td>0.404</td><td>1.000</td><td>1.000</td><td>49</td><td>tags=28%, list=12%, signal=30%</td></tr><tr><td class='lessen'>45</td><td>BENPORATH_SUZ12_TARGETS</td><td></td><td>16</td><td>-0.37</td><td>-1.09</td><td>0.397</td><td>1.000</td><td>1.000</td><td>112</td><td>tags=63%, list=27%, signal=82%</td></tr><tr><td class='lessen'>46</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>23</td><td>-0.34</td><td>-1.09</td><td>0.369</td><td>1.000</td><td>1.000</td><td>49</td><td>tags=22%, list=12%, signal=23%</td></tr><tr><td class='lessen'>47</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</td><td></td><td>19</td><td>-0.37</td><td>-1.08</td><td>0.413</td><td>1.000</td><td>1.000</td><td>64</td><td>tags=32%, list=15%, signal=36%</td></tr><tr><td class='lessen'>48</td><td>LEE_BMP2_TARGETS_UP</td><td></td><td>42</td><td>-0.30</td><td>-1.08</td><td>0.382</td><td>0.994</td><td>1.000</td><td>56</td><td>tags=19%, list=13%, signal=20%</td></tr><tr><td class='lessen'>49</td><td>THUM_SYSTOLIC_HEART_FAILURE_UP</td><td></td><td>15</td><td>-0.38</td><td>-1.06</td><td>0.432</td><td>1.000</td><td>1.000</td><td>14</td><td>tags=13%, list=3%, signal=13%</td></tr><tr><td class='lessen'>50</td><td>KAYO_AGING_MUSCLE_DN</td><td></td><td>15</td><td>-0.37</td><td>-1.06</td><td>0.427</td><td>1.000</td><td>1.000</td><td>5</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>51</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>22</td><td>-0.33</td><td>-1.03</td><td>0.450</td><td>1.000</td><td>1.000</td><td>68</td><td>tags=32%, list=16%, signal=36%</td></tr><tr><td class='lessen'>52</td><td>REACTOME_ADAPTIVE_IMMUNE_SYSTEM</td><td></td><td>19</td><td>-0.34</td><td>-1.03</td><td>0.444</td><td>1.000</td><td>1.000</td><td>144</td><td>tags=68%, list=34%, signal=100%</td></tr><tr><td class='lessen'>53</td><td>BENPORATH_CYCLING_GENES</td><td></td><td>25</td><td>-0.32</td><td>-1.02</td><td>0.449</td><td>1.000</td><td>1.000</td><td>4</td><td>tags=4%, list=1%, signal=4%</td></tr><tr><td class='lessen'>54</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_DN</td><td></td><td>15</td><td>-0.37</td><td>-1.02</td><td>0.453</td><td>1.000</td><td>1.000</td><td>6</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>55</td><td>YAMAZAKI_TCEB3_TARGETS_UP</td><td></td><td>17</td><td>-0.35</td><td>-1.01</td><td>0.459</td><td>1.000</td><td>1.000</td><td>131</td><td>tags=71%, list=31%, signal=99%</td></tr><tr><td class='lessen'>56</td><td>LIAO_METASTASIS</td><td></td><td>19</td><td>-0.33</td><td>-1.01</td><td>0.480</td><td>0.994</td><td>1.000</td><td>24</td><td>tags=16%, list=6%, signal=16%</td></tr><tr><td class='lessen'>57</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</td><td></td><td>18</td><td>-0.34</td><td>-1.00</td><td>0.485</td><td>0.999</td><td>1.000</td><td>37</td><td>tags=22%, list=9%, signal=23%</td></tr><tr><td class='lessen'>58</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>47</td><td>-0.26</td><td>-0.97</td><td>0.480</td><td>1.000</td><td>1.000</td><td>58</td><td>tags=19%, list=14%, signal=20%</td></tr><tr><td class='lessen'>59</td><td>PEREZ_TP53_TARGETS</td><td></td><td>17</td><td>-0.32</td><td>-0.94</td><td>0.528</td><td>1.000</td><td>1.000</td><td>85</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>60</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td><td></td><td>17</td><td>-0.32</td><td>-0.94</td><td>0.530</td><td>1.000</td><td>1.000</td><td>70</td><td>tags=24%, list=17%, signal=27%</td></tr><tr><td class='lessen'>61</td><td>REACTOME_INNATE_IMMUNE_SYSTEM</td><td></td><td>49</td><td>-0.25</td><td>-0.93</td><td>0.558</td><td>1.000</td><td>1.000</td><td>34</td><td>tags=14%, list=8%, signal=14%</td></tr><tr><td class='lessen'>62</td><td>BENPORATH_ES_WITH_H3K27ME3</td><td></td><td>15</td><td>-0.32</td><td>-0.92</td><td>0.548</td><td>1.000</td><td>1.000</td><td>112</td><td>tags=60%, list=27%, signal=79%</td></tr><tr><td class='lessen'>63</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td><td></td><td>18</td><td>-0.31</td><td>-0.91</td><td>0.581</td><td>1.000</td><td>1.000</td><td>87</td><td>tags=39%, list=21%, signal=47%</td></tr><tr><td class='lessen'>64</td><td>IGLESIAS_E2F_TARGETS_UP</td><td></td><td>28</td><td>-0.27</td><td>-0.89</td><td>0.576</td><td>1.000</td><td>1.000</td><td>12</td><td>tags=7%, list=3%, signal=7%</td></tr><tr><td class='lessen'>65</td><td>BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP</td><td></td><td>23</td><td>-0.28</td><td>-0.88</td><td>0.624</td><td>1.000</td><td>1.000</td><td>112</td><td>tags=48%, list=27%, signal=62%</td></tr><tr><td class='lessen'>66</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</td><td></td><td>16</td><td>-0.31</td><td>-0.88</td><td>0.582</td><td>1.000</td><td>1.000</td><td>8</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>67</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>34</td><td>-0.25</td><td>-0.87</td><td>0.610</td><td>1.000</td><td>1.000</td><td>91</td><td>tags=32%, list=22%, signal=38%</td></tr><tr><td class='lessen'>68</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>41</td><td>-0.24</td><td>-0.85</td><td>0.621</td><td>1.000</td><td>1.000</td><td>18</td><td>tags=7%, list=4%, signal=7%</td></tr><tr><td class='lessen'>69</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td><td></td><td>19</td><td>-0.28</td><td>-0.85</td><td>0.634</td><td>1.000</td><td>1.000</td><td>109</td><td>tags=42%, list=26%, signal=54%</td></tr><tr><td class='lessen'>70</td><td>CUI_TCF21_TARGETS_2_DN</td><td></td><td>25</td><td>-0.27</td><td>-0.84</td><td>0.622</td><td>1.000</td><td>1.000</td><td>46</td><td>tags=20%, list=11%, signal=21%</td></tr><tr><td class='lessen'>71</td><td>JAEGER_METASTASIS_DN</td><td></td><td>21</td><td>-0.27</td><td>-0.84</td><td>0.627</td><td>1.000</td><td>1.000</td><td>43</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>72</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</td><td></td><td>28</td><td>-0.26</td><td>-0.84</td><td>0.621</td><td>1.000</td><td>1.000</td><td>112</td><td>tags=50%, list=27%, signal=64%</td></tr><tr><td class='lessen'>73</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>17</td><td>-0.28</td><td>-0.84</td><td>0.615</td><td>1.000</td><td>1.000</td><td>24</td><td>tags=12%, list=6%, signal=12%</td></tr><tr><td class='lessen'>74</td><td>REACTOME_METABOLISM_OF_LIPIDS</td><td></td><td>23</td><td>-0.26</td><td>-0.83</td><td>0.659</td><td>1.000</td><td>1.000</td><td>15</td><td>tags=9%, list=4%, signal=9%</td></tr><tr><td class='lessen'>75</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>26</td><td>-0.25</td><td>-0.83</td><td>0.638</td><td>1.000</td><td>1.000</td><td>22</td><td>tags=8%, list=5%, signal=8%</td></tr><tr><td class='lessen'>76</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_UP</td><td></td><td>27</td><td>-0.24</td><td>-0.81</td><td>0.666</td><td>1.000</td><td>1.000</td><td>82</td><td>tags=30%, list=20%, signal=34%</td></tr><tr><td class='lessen'>77</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</td><td></td><td>16</td><td>-0.28</td><td>-0.80</td><td>0.645</td><td>1.000</td><td>1.000</td><td>124</td><td>tags=56%, list=30%, signal=77%</td></tr><tr><td class='lessen'>78</td><td>LI_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>44</td><td>-0.20</td><td>-0.75</td><td>0.728</td><td>1.000</td><td>1.000</td><td>4</td><td>tags=2%, list=1%, signal=2%</td></tr><tr><td class='lessen'>79</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>31</td><td>-0.22</td><td>-0.74</td><td>0.740</td><td>1.000</td><td>1.000</td><td>25</td><td>tags=10%, list=6%, signal=10%</td></tr><tr><td class='lessen'>80</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>19</td><td>-0.24</td><td>-0.73</td><td>0.716</td><td>1.000</td><td>1.000</td><td>74</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>81</td><td>PATIL_LIVER_CANCER</td><td></td><td>28</td><td>-0.22</td><td>-0.72</td><td>0.755</td><td>1.000</td><td>1.000</td><td>32</td><td>tags=11%, list=8%, signal=11%</td></tr><tr><td class='lessen'>82</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td><td></td><td>17</td><td>-0.24</td><td>-0.71</td><td>0.722</td><td>1.000</td><td>1.000</td><td>12</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>83</td><td>BENPORATH_EED_TARGETS</td><td></td><td>18</td><td>-0.24</td><td>-0.70</td><td>0.765</td><td>1.000</td><td>1.000</td><td>71</td><td>tags=33%, list=17%, signal=38%</td></tr><tr><td class='lessen'>84</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>17</td><td>-0.24</td><td>-0.69</td><td>0.763</td><td>1.000</td><td>1.000</td><td>24</td><td>tags=12%, list=6%, signal=12%</td></tr><tr><td class='lessen'>85</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_DN</td><td></td><td>19</td><td>-0.23</td><td>-0.68</td><td>0.774</td><td>1.000</td><td>1.000</td><td>25</td><td>tags=11%, list=6%, signal=11%</td></tr><tr><td class='lessen'>86</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td><td></td><td>21</td><td>-0.22</td><td>-0.68</td><td>0.780</td><td>1.000</td><td>1.000</td><td>25</td><td>tags=10%, list=6%, signal=10%</td></tr><tr><td class='lessen'>87</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>21</td><td>-0.22</td><td>-0.67</td><td>0.792</td><td>1.000</td><td>1.000</td><td>49</td><td>tags=14%, list=12%, signal=15%</td></tr><tr><td class='lessen'>88</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td><td></td><td>32</td><td>-0.20</td><td>-0.66</td><td>0.836</td><td>1.000</td><td>1.000</td><td>91</td><td>tags=28%, list=22%, signal=33%</td></tr><tr><td class='lessen'>89</td><td>NUYTTEN_EZH2_TARGETS_UP</td><td></td><td>37</td><td>-0.18</td><td>-0.65</td><td>0.828</td><td>1.000</td><td>1.000</td><td>131</td><td>tags=46%, list=31%, signal=61%</td></tr><tr><td class='lessen'>90</td><td>SWEET_LUNG_CANCER_KRAS_DN</td><td></td><td>22</td><td>-0.20</td><td>-0.65</td><td>0.817</td><td>1.000</td><td>1.000</td><td>49</td><td>tags=23%, list=12%, signal=24%</td></tr><tr><td class='lessen'>91</td><td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td><td></td><td>25</td><td>-0.20</td><td>-0.65</td><td>0.808</td><td>1.000</td><td>1.000</td><td>24</td><td>tags=8%, list=6%, signal=8%</td></tr><tr><td class='lessen'>92</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</td><td></td><td>51</td><td>-0.17</td><td>-0.64</td><td>0.843</td><td>1.000</td><td>1.000</td><td>11</td><td>tags=4%, list=3%, signal=4%</td></tr><tr><td class='lessen'>93</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</td><td></td><td>20</td><td>-0.21</td><td>-0.63</td><td>0.828</td><td>1.000</td><td>1.000</td><td>109</td><td>tags=35%, list=26%, signal=45%</td></tr><tr><td class='lessen'>94</td><td>BERENJENO_TRANSFORMED_BY_RHOA_DN</td><td></td><td>17</td><td>-0.22</td><td>-0.62</td><td>0.831</td><td>1.000</td><td>1.000</td><td>111</td><td>tags=47%, list=27%, signal=61%</td></tr><tr><td class='lessen'>95</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_DN</td><td></td><td>32</td><td>-0.18</td><td>-0.62</td><td>0.870</td><td>1.000</td><td>1.000</td><td>8</td><td>tags=3%, list=2%, signal=3%</td></tr><tr><td class='lessen'>96</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</td><td></td><td>30</td><td>-0.18</td><td>-0.61</td><td>0.859</td><td>1.000</td><td>1.000</td><td>63</td><td>tags=17%, list=15%, signal=18%</td></tr><tr><td class='lessen'>97</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>35</td><td>-0.18</td><td>-0.61</td><td>0.869</td><td>1.000</td><td>1.000</td><td>7</td><td>tags=3%, list=2%, signal=3%</td></tr><tr><td class='lessen'>98</td><td>GRUETZMANN_PANCREATIC_CANCER_DN</td><td></td><td>16</td><td>-0.21</td><td>-0.60</td><td>0.857</td><td>1.000</td><td>1.000</td><td>152</td><td>tags=56%, list=36%, signal=85%</td></tr><tr><td class='lessen'>99</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP</td><td></td><td>19</td><td>-0.19</td><td>-0.59</td><td>0.869</td><td>1.000</td><td>1.000</td><td>74</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>100</td><td>ACEVEDO_LIVER_CANCER_UP</td><td></td><td>29</td><td>-0.17</td><td>-0.58</td><td>0.872</td><td>1.000</td><td>1.000</td><td>91</td><td>tags=28%, list=22%, signal=33%</td></tr><tr><td class='lessen'>101</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN</td><td></td><td>23</td><td>-0.18</td><td>-0.58</td><td>0.875</td><td>1.000</td><td>1.000</td><td>152</td><td>tags=57%, list=36%, signal=84%</td></tr><tr><td class='lessen'>102</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>34</td><td>-0.17</td><td>-0.58</td><td>0.877</td><td>1.000</td><td>1.000</td><td>139</td><td>tags=47%, list=33%, signal=65%</td></tr><tr><td class='lessen'>103</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>16</td><td>-0.20</td><td>-0.58</td><td>0.841</td><td>1.000</td><td>1.000</td><td>292</td><td>tags=94%, list=70%, signal=299%</td></tr><tr><td class='lessen'>104</td><td>YAGI_AML_WITH_T_8_21_TRANSLOCATION</td><td></td><td>16</td><td>-0.20</td><td>-0.58</td><td>0.872</td><td>1.000</td><td>1.000</td><td>93</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>105</td><td>REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION</td><td></td><td>41</td><td>-0.16</td><td>-0.58</td><td>0.905</td><td>0.996</td><td>1.000</td><td>128</td><td>tags=41%, list=31%, signal=54%</td></tr><tr><td class='lessen'>106</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td><td></td><td>23</td><td>-0.17</td><td>-0.55</td><td>0.877</td><td>1.000</td><td>1.000</td><td>104</td><td>tags=35%, list=25%, signal=44%</td></tr><tr><td class='lessen'>107</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>30</td><td>-0.16</td><td>-0.55</td><td>0.905</td><td>1.000</td><td>1.000</td><td>9</td><td>tags=3%, list=2%, signal=3%</td></tr><tr><td class='lessen'>108</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>18</td><td>-0.18</td><td>-0.53</td><td>0.906</td><td>1.000</td><td>1.000</td><td>92</td><td>tags=28%, list=22%, signal=34%</td></tr><tr><td class='lessen'>109</td><td>NUYTTEN_NIPP1_TARGETS_DN</td><td></td><td>46</td><td>-0.14</td><td>-0.53</td><td>0.926</td><td>1.000</td><td>1.000</td><td>39</td><td>tags=9%, list=9%, signal=9%</td></tr><tr><td class='lessen'>110</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>25</td><td>-0.16</td><td>-0.51</td><td>0.930</td><td>1.000</td><td>1.000</td><td>226</td><td>tags=72%, list=54%, signal=147%</td></tr><tr><td class='lessen'>111</td><td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td><td></td><td>16</td><td>-0.18</td><td>-0.51</td><td>0.911</td><td>0.994</td><td>1.000</td><td>347</td><td>tags=100%, list=83%, signal=566%</td></tr><tr><td class='lessen'>112</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN</td><td></td><td>16</td><td>-0.18</td><td>-0.51</td><td>0.930</td><td>0.987</td><td>1.000</td><td>66</td><td>tags=19%, list=16%, signal=21%</td></tr><tr><td class='lessen'>113</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>21</td><td>-0.16</td><td>-0.50</td><td>0.920</td><td>0.982</td><td>1.000</td><td>331</td><td>tags=95%, list=79%, signal=435%</td></tr><tr><td class='lessen'>114</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>47</td><td>-0.14</td><td>-0.50</td><td>0.942</td><td>0.976</td><td>1.000</td><td>18</td><td>tags=4%, list=4%, signal=4%</td></tr><tr><td class='lessen'>115</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td><td></td><td>43</td><td>-0.14</td><td>-0.49</td><td>0.957</td><td>0.969</td><td>1.000</td><td>7</td><td>tags=2%, list=2%, signal=2%</td></tr><tr><td class='lessen'>116</td><td>LU_EZH2_TARGETS_UP</td><td></td><td>16</td><td>-0.16</td><td>-0.46</td><td>0.963</td><td>0.981</td><td>1.000</td><td>355</td><td>tags=100%, list=85%, signal=638%</td></tr><tr><td class='lessen'>117</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_UP</td><td></td><td>26</td><td>-0.13</td><td>-0.41</td><td>0.977</td><td>0.994</td><td>1.000</td><td>279</td><td>tags=81%, list=67%, signal=228%</td></tr><tr><td class='lessen'>118</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN</td><td></td><td>17</td><td>-0.12</td><td>-0.35</td><td>0.982</td><td>1.000</td><td>1.000</td><td>49</td><td>tags=18%, list=12%, signal=19%</td></tr><tr><td class='lessen'>119</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</td><td></td><td>26</td><td>-0.10</td><td>-0.32</td><td>0.997</td><td>0.996</td><td>1.000</td><td>137</td><td>tags=42%, list=33%, signal=59%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1605123009056.tsv'>[plain text format]</a></caption></table></div><br></body></html>